CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- SC 13D Stake Beneficial Ownership Report
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 10QSB/A Other 10QSB/A
- 10QSB Other 10QSB
- SC 13D Stake Beneficial Ownership Report
- 8-K/A Event Item 1 · Item 7
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Item 1 · Item 7
- DEF 14C Other DEF 14C
- 8-K Event Item 5
- PRER14C Other PRER14C
- PRE 14C Other PRE 14C
- 5 Insider Annual Insider Trading Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Item 5 · Item 7
- 10QSB Other 10QSB
- SC 13D Stake Beneficial Ownership Report
Page 43 of 46 · 904 filings